Connect with us

Hi, what are you looking for?

Life

Breakthrough in personalized breast cancer medicine

The new technology is referred to as ProFound AI™ Risk. This is described as the only commercially available clinical decision support tool, and its importance is contained within the fact that breast cancer is one of the most common cancers in women around the world. The platform brings together an assessment of different risk factors in order to help to improve breast cancer diagnosis. The factors assessed include age, breast density and subtle mammographic features.

These factors come together in order to provide an estimate of a woman’s two-year risk of developing breast cancer. By applying the technology, medics can draw an accurate assessment based on each individual patient who is presented for an examination. The personalized approach is more in-tune with each individual and this contrasts with a more generic approach to make diagnoses.

With the Profound technology, this has recently been issued with CE Marking. CE marking is a certification mark that indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area (EEA).

The technology has been clinically proven to be more accurate in assessing short-term risk compared to traditional breast cancer risk models, which provide a 5-year or 10-year estimate. This shorter-term risk estimate provides clinicians with key information that can help them tailor patients’ breast screening regimens and potentially identify cancers earlier.

iCAD recently unveiled the technology, virtually, at the European Congress of Radiology (ECR) digital meeting, where new data will was presented to support ProFound AI, iCAD’s deep-learning, artificial intelligence cancer detection software solution, which is available for 2D and 3D mammography. Studies have shown how the application of artificial intelligence for this form of cancer screening can improve the sensitivity, and specificity of the assessment. In addition, there is evidence that shows a reduction in recall rate as well as data reading times.

Avatar photo
Written By

Dr. Tim Sandle is Digital Journal's Editor-at-Large for science news. Tim specializes in science, technology, environmental, business, and health journalism. He is additionally a practising microbiologist; and an author. He is also interested in history, politics and current affairs.

You may also like:

Business

DOGE has said nothing at all about what happens next. Guesses?

Business

A flood of presidential trade policy announcements has kept US automakers on edge since Donald Trump returned to the White House.

Entertainment

Lady Gaga tribute performer Tierney chatted about her latest endeavors in the music industry.

Entertainment

Papal thriller "Conclave" and immigrant epic "The Brutalist" on Sunday tied for top honours at Britain's BAFTA awards.